openPR Logo
Press release

Prosthetic Heart Valve Market to Reach US$ 18.6 Billion by 2033 at 7.9% CAGR; North America Leads with 38% Share; Key Players Include Edwards Lifesciences, Boston Scientific

01-06-2026 11:54 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Prosthetic Heart Valve Market

Prosthetic Heart Valve Market

The global Prosthetic Heart Valve Market reached US$ 9.4 billion in 2024 and is expected to reach US$ 18.6 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of valvular heart diseases, increasing aging population, and growing adoption of minimally invasive cardiac procedures worldwide.

Prosthetic heart valves are medical devices used to replace damaged or diseased natural heart valves and are broadly categorized into mechanical and bioprosthetic valves. These devices are widely used in the treatment of conditions such as aortic stenosis, mitral regurgitation, and congenital heart valve disorders. Technological advancements in transcatheter heart valve replacement (TAVR/TAVI), improved biomaterials, and enhanced valve durability are significantly improving patient outcomes and expanding the eligible patient pool. Increasing awareness of early diagnosis, expanding access to advanced cardiac care, and continuous innovation by leading cardiovascular device manufacturers are collectively supporting the sustained growth of the prosthetic heart valve market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/prosthetic-heart-valve-market?sai-v

The Prosthetic Heart Valve Market refers to the global industry involved in the development, manufacturing, and commercialization of artificial heart valves used to replace or support diseased native heart valves.

Key Developments
✅ January 2026: In North America, innovative transcatheter heart valve systems with improved hemodynamic performance gained wider adoption, helping expand treatment options for high-risk patients.

✅ December 2025: In Europe, hospitals increased use of minimally invasive valve replacement procedures supported by next-generation prosthetic heart valves designed for enhanced durability.

✅ November 2025: In Asia-Pacific, clinical centers reported growing utilization of sutureless and rapid-deployment valve technologies to reduce operative times in cardiac surgery.

✅ October 2025: In Latin America, cardiac care units stepped up implantation of bioprosthetic heart valves to improve quality of life in aging patient populations with valvular disease.

✅ September 2025: In the Middle East, awareness campaigns and heart health initiatives led to expanded screening for valvular conditions and referral for prosthetic valve interventions.

✅ August 2025: In Africa, pilot cardiac programs introduced training on prosthetic heart valve implantation techniques to build local surgical expertise.

Mergers & Acquisitions
✅ January 2026: In North America, a leading medical devices company acquired an advanced transcatheter heart valve developer to strengthen its cardiovascular portfolio.

✅ December 2025: In Europe, a global heart valve manufacturer acquired a regional surgical valve technology firm to broaden its product offerings in key markets.

✅ November 2025: In Asia-Pacific, a healthcare technology group acquired a distributor specializing in prosthetic heart valve devices to deepen market presence in emerging hospital networks.

Key Players
Edwards Lifesciences Corporation | Boston Scientific Corporation | St. Jude Medical Inc. | Symetis SA | JenaValve Technology Inc. | CryoLife Inc. | TTK Healthcare Limited | Colibri Heart Valve LLC | Lepu Medical Technology Co. Ltd.

Key Highlights
Edwards Lifesciences Corporation - Holds 34.6% share, driven by global leadership in transcatheter heart valve technologies, strong clinical evidence, and widespread adoption of TAVR systems.

Boston Scientific Corporation - Holds 18.9% share, supported by advanced structural heart solutions, expanding transcatheter valve portfolio, and strong global commercialization capabilities.

St. Jude Medical Inc. - Holds 14.2% share, benefiting from established cardiac device expertise, broad hospital penetration, and legacy strength in heart valve and cardiovascular therapies.

Symetis SA - Holds 8.1% share, focused on minimally invasive transcatheter aortic valve solutions with growing adoption in European markets.

JenaValve Technology Inc. - Holds 7.3% share, driven by innovative valve designs addressing aortic regurgitation and expanding clinical trial progress.

CryoLife Inc. - Holds 6.2% share, leveraging expertise in surgical heart valves, tissue processing technologies, and strong presence in conventional valve replacement procedures.

Lepu Medical Technology Co. Ltd. - Holds 5.1% share, supported by cost-effective transcatheter and surgical valve offerings and strong growth in Asia-Pacific markets.

TTK Healthcare Limited - Holds 3.4% share, driven by domestic manufacturing capabilities and steady demand for surgical heart valves in emerging economies.

Colibri Heart Valve LLC - Holds 2.2% share, focused on next-generation, pre-mounted transcatheter heart valve technologies under clinical development.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=prosthetic-heart-valve-market?sai-v

Market Drivers
- Rising prevalence of valvular heart diseases such as aortic stenosis and mitral regurgitation increasing demand for valve replacement therapies.

- Growing aging population globally leading to higher incidence of degenerative heart valve disorders.

- Increasing adoption of minimally invasive and transcatheter heart valve replacement procedures.

- Advancements in prosthetic valve design improving durability, hemodynamic performance, and patient outcomes.

- Expansion of cardiac care infrastructure and availability of specialized cardiovascular centers worldwide.

Industry Developments
- Continuous innovation in mechanical and bioprosthetic heart valve - technologies.

- Rising adoption of transcatheter aortic and mitral valve replacement systems.

- Strategic collaborations between medical device manufacturers and cardiac care providers.

- Expansion of manufacturing capabilities to meet growing global demand for heart valve devices.

- Ongoing clinical trials and regulatory approvals supporting new-generation prosthetic heart valves.

Regional Insights
North America - 38% share: "Driven by advanced cardiovascular care infrastructure, high adoption of transcatheter procedures, strong reimbursement support, and early uptake of innovative valve technologies."

Europe - 27% share: "Supported by established cardiac surgery centers, growing adoption of minimally invasive valve replacement, and strong regulatory frameworks."

Asia Pacific - 28% share: "Fueled by rising cardiovascular disease burden, expanding cardiac care infrastructure, increasing access to advanced treatments, and growing medical tourism."

Latin America - 4% share: "Driven by improving access to cardiac surgery, expansion of specialty hospitals, and increasing adoption of advanced heart valve treatments."

Middle East & Africa - 3% share: "Supported by healthcare infrastructure development, rising investments in cardiovascular care, and growing awareness of heart valve disease treatment."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/prosthetic-heart-valve-market?sai-v

Key Segments

By Product Type
Transcatheter heart valves dominate the market, driven by increasing adoption of minimally invasive procedures and favorable outcomes in high-risk and elderly patients. Mechanical heart valves hold a significant share, supported by their long durability and preference in younger patient populations. Tissue heart valves represent a substantial segment, driven by reduced need for long-term anticoagulation and growing use in surgical valve replacement procedures.

By End User
Hospitals account for the largest share of the market, driven by advanced surgical infrastructure and high volumes of valve replacement procedures. Ambulatory surgical centers hold a notable share, supported by the shift toward minimally invasive interventions and shorter hospital stays. Cardiac centers contribute significantly due to their specialization in cardiovascular care and adoption of advanced valve technologies.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prosthetic Heart Valve Market to Reach US$ 18.6 Billion by 2033 at 7.9% CAGR; North America Leads with 38% Share; Key Players Include Edwards Lifesciences, Boston Scientific here

News-ID: 4337489 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Mobile Mapping Systems Market to Reach US$ 86.7 Billion by 2030, Driven by Rapid Urbanization, Autonomous Vehicle Development, and 5G-Enabled High-Precision Mapping
Mobile Mapping Systems Market to Reach US$ 86.7 Billion by 2030, Driven by Rapid …
According to DataM Intelligence, the global mobile mapping systems market reached US$ 34.5 billion in 2022 and is expected to reach US$ 86.7 billion by 2030, growing at a CAGR of 19.5% during the forecast period 2024-2031. Growth is propelled by increasing demand for accurate geospatial data, expansion of smart cities and infrastructure projects, advancements in LiDAR, GNSS, and camera technologies, rising adoption in autonomous vehicles and location-based services, and
Dystrophin Gene Therapy Market to Reach US$ 12.00 Billion by 2033, Powered by Expanding Approvals, Clinical Progress, and Rising Demand for Duchenne Muscular Dystrophy Treatments
Dystrophin Gene Therapy Market to Reach US$ 12.00 Billion by 2033, Powered by Ex …
According to DataM Intelligence, the global dystrophin gene therapy market reached US$ 1.91 billion in 2024 and is expected to reach US$ 12.00 billion by 2033, growing at a CAGR of 20.6% during the forecast period 2025-2033. Growth is driven by increasing approvals and label expansions for approved therapies, promising clinical trial advancements in AAV-based gene therapies, rising prevalence of Duchenne muscular dystrophy (DMD), high unmet need for disease-modifying treatments,
Medical Electronics Market to Reach US$ 386.4 Billion by 2033 at 8.1% CAGR; North America Leads with 35% Share; Key Players Include Medtronic, GE Healthcare, Philips
Medical Electronics Market to Reach US$ 386.4 Billion by 2033 at 8.1% CAGR; Nort …
The global Medical Electronics Market reached US$ 192.6 billion in 2024 and is expected to reach US$ 386.4 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033. Market growth is driven by rapid technological advancements, increasing prevalence of chronic diseases, and rising demand for advanced diagnostic, monitoring, and therapeutic medical devices across healthcare systems worldwide. Medical electronics encompass electronic components and systems used in medical equipment
Computer Numerical Control Machines Market Set for Strong Growth at 10.5% CAGR Through 2031, Led by Asia Pacific's 52% Market Share | DataM Intelligence
Computer Numerical Control Machines Market Set for Strong Growth at 10.5% CAGR T …
The Computer Numerical Control Machines Market is expected to grow at a CAGR of 10.5% during the forecast period (2024-2031). Market growth stems from industries adopting IoT-enabled automation to enhance manufacturing efficiency and productivity. Technological advancements, such as 4-axis and 5-axis movements for higher accuracy, alongside rising demand in automotive and electronics sectors for complex machining, further propel expansion. Integration with industrial robots and simulation software addresses skilled labor shortages, boosting

All 5 Releases


More Releases for Valve

Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure. According to Fact.MR’s
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market
Global Plug Valves Market: Yuandong Valve, Yuanda Valve, Weir, Walworth, Zhengqu …
Global Market Study Evaluate on Plug Valves Industry by Type, Manufacturers, Application, Type, and Regions, Forecast up to 2022 The scope of the global Plug Valves market report is: This report offers a comprehensive evaluation of the Plug Valves market. It does so by in-depth qualitative insights, historical Plug Valves market data, and verifiable projections about global Plug Valves market size. The projections featured in the Plug Valves market report have been